ArticleClinical pharmacokinetics2023

Pharmacokinetics and Safety of Cotadutide, a GLP-1 and Glucagon Receptor Dual Agonist, in Individuals with Renal Impairment: A Single-Dose, Phase I, Bridging Study.

Gernot Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.